Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The rotavirus VP8* protein is a domain located at the distal end of the viral spike protein VP4. It plays a critical role in mediating the initial attachment of rotaviruses to host cells by binding to specific cell surface glycans, which facilitates viral entry and infection. The receptor specificity of VP8* varies among rotavirus strains, with animal rotaviruses often binding terminal sialic acid residues and human rotaviruses interacting with histo-blood group antigens (HBGAs). This interaction influences host range, tissue tropism, and susceptibility to infection. VP8* is a key target for neutralizing antibodies and vaccine development.
Antibodies targeting VP8* can block virus-cell attachment, neutralizing viral infectivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP8* Protein (VP8*).